The Effect of Aerobic Training and Taxol Consumption on IL 8 and PAI-1 in Cervical Cancer

Authors: Alireza Barari, Maryam Firoozi, Maryam Ebrahimzadeh, Romina Roohani Ardeshiri, Maryam Kamarloeei

Abstract:

Background: The purpose of this study was to analyze the effect of six-week aerobic training and taxol consumption on interleukin-8 and Plasminogen Activator Inhibitor-1 (PAI-1) in mice with cervical cancer. Materials and Methods: In this experimental study, 40 female C57 mice with cervical cancer, eight weeks old, were randomly divided into 4 groups including: control, taxol supplement, training, and training-taxol supplement. The implantation of cancerous tumors was performed under the skin at the upper of the pelvis. The program training was included: endurance training for six weeks, 3 sessions per week and 50 minutes per session, at the speed of 14-18 m/s. Taxol supplement at a dose of 60 mg/kg per day was injected intraperitoneally. Data analysis was performed using t-test and one-way ANOVA and if statistically significant, Bonferroni post hoc was used at the significance level p < .05. Results: The results showed that there was a significant difference between the levels of interleukin 8 (P < 0.05, F = 12.25) and the PAI-1 (P < 0.05, P = 0.10737 between the 4 groups. The results of this study showed a significant difference between the control group and the training - complementary group. Six weeks of aerobic training and taxol consumption have a significant effect on the level of PAI-1 and interleukin-8 mice with cervical cancer. Conclusion: Considering the effect of training on these variables, this type of exercise can be used as a complementary therapeutic approach with other therapies for cervical cancer.

Keywords: Cervical cancer, taxol, endurance training, interleukin 8, plasminogen activator inhibitor-1.

References:

[1] Dannenberg AJ, Altork: NK, Boyle Jo, Dang C, Howe LR, weksler BB, et al. Cyclooxygense 2: a pharmacological target for the prevention of cancer. Lancet oncol; 2001; 2:544-51.
[2] Kim JH, Banton SA, Awad M, Yadalam A, Sher S, et al Training-Related Metabolic Adaptations in American-Style Football Partici¬pants. Ann Sports Med Res,2015; 2(8): 1048.
[3] Kazemi A, Agha Alinejad H, Eslami R, Ehsan P, Baghaei R, Dabaghzadeh R et al . Investigating the Effect of Endurance Training on Tumor Level of IL-8 and Serum Level of IL-17 in Female Mice with Breast Cancer. J FasaUniv Med Sci. 2015; 5 (3) :347-355
[4] Snoussi, K., Mahfoudh, W., Bouaouina, N., Ahmed, S.B.,Helal, A. N., Chouchane, L. (2008). Genetic variation in IL-8associated with increased risk and poor prognosis of breastcarcinoma. Hum Immunol, 67(1-2), 13-21.
[5] Shao, N., Lu, Z., Zhang, Y., Wang, M., Li, W., Hu, Z. (2015). Interlukin 8 Upregulates integrin B3 Expression and Promotes estrogen receptor- negative breast cancer cell invasion by activating the Pi3k/AKt/ NF- KB Pathway. Cancer let, 364(2), 165- 172.
[6] Shaghaghi Z, Bonyadi M, Somi MH, Khoshbaten M. Association of plasminogen activator inhibitor-1 gene polymorphism with inflammatory bowel disease in Iranian Azari Turkish patients. Saudi J Gastroenterol 2014; 20(1): 54-8.
[7] YasarYildiz S, Kuru P, ToksoyOner E, Agirbasli M. Functional stability of plasminogen activator inhibitor-1. SciWorld J 2014; 2014: 858293.
[8] Horvaticherceg G, Herceg D, Kralik M, Kulic A, Bencezigman Z, TomicbBrzac H, et al. Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients. Otolaryngol Head Neck Surg 2013; 149:533-40.
[9] Horvaticherceg G, Herceg D, Kralik M, Bencezigman Z, Tomicbrzac H, Kulic A. Urokinasetype plasminogen activator and its inhibitor in thyroid neoplasms a cytosol study. Wien KlinWochenschr 2006; 118:601-9.
[10] Hazelbag, S., Kenter, G. G., Gorter, A., Fleuren, G. J. (2004). Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer, Int J Cancer, 112(6), 1020-8.
[11] Capelli, K., Felicetti, M., Capomaccio, S., Pieramati, C., Silvestrelli, M., Verini-Supplizi, A. (2009), Exercise-induced up-regulation of MMP-1 and IL-8 genes in endurance horses. BMC Physiol, 24, 9-12.
[12] Addison, C.L., Daniel, T.O., Burdick, M.D., Liu, H., Ehlert, J. E., Xue, Y. Y. (2000). The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+CXC chemokine-induced angiogenic activity. J Immunol, 165, 5269-5277.
[13] Nieman, D. C., Davis, J. M., Henson, D. A., Walberg- Rankin, J., Shute, M., Dumke, C. L. (2003). Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J ApplPhysiol, 94, 1917- 25.
[14] Cooper, J. A., Nagelkirk, P. R., Coughlin, A. M., Pivarnik, J. M., Womack, C. J. (2004). Temporal changes in tPA and PAI-1 after maximal exercise, Med Sci Sports Exerc, 36(11), 1884-1887.
[15] Väisänen, S. B., Humphries, S. E., Luong, L. A., Penttilä, I., Bouchard, C., Rauramaa, R. (2000). Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene, ThrombHaemost, 82(3), 1117-20.
[16] Hla T, Bailey DB, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and-2 isoenzymes. IYBCB 1999; 31:551-57.
[17] Kim JH, Banton SA, Awad M, Yadalam A, Sher S, et al Training-Related Metabolic Adaptations in American-Style Football Partici¬pants. Ann Sports Med Res,2015; 2(8): 1048.
[18] Barari A, Mojhde M, Farzanegi P and Ghasemi M. Effect of Six Weeks of Endurance Training and Aloe Vera on COX-2 and MMP-9 Levels in Mice with Breast Cancer. Journal of ShahidSadoughi University of Medical Science. Apr 2016; 24 (1):65-73
[19] Murphy, E. A., Davis, J. M., Barrilleaux, T., McClellan, J., Steiner, J., Carmichael, M.(2011). Benefits of exercise training on breast cancer progression and inflammation in C3 (1)SV40Tag mice. Cytokine, 55(2), 274-9.
[20] Korkaya H, Liu S, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 2011;121: 3804–9.
[21] Vendramini-Costa DB, Carvalho JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012;18:3831–52.
[22] Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol2009;27:3437–44.S
[23] Shao N, Chen LH, Ye RY, Lin Y, Wang SM. The depletion of interleukin-8 cause’s cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells. BiochemBiophys Res Commun. 2013; 431(3):535-41.
[24] Mohammadi-Motlagh Hamid-Reza, Mansouri Kamran, Mostafaie Ali. Plants as useful agents for angiogenesis and tumor growth prevention. Physiology and Pharmacology, 2010; 14 (3), 297-312.
[25] Oaknin A, Díaz de Corcuera I, Rodríguez-Freixinós V, Rivera F, del Campo JM. SEOM guidelines for cervical cancer. ClinTranslOncol. 2012;14(7):516-9.
[26] Rogers LQ. , Amanda Fogleman, Rita Trammell, Patricia Hopkins-Price, Sandy Vicari, Krishna Rao, Billie Edson, Steven Verhulst, Kerry S. Courneya, and Karen Hoelzer. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther. 2013 Jul; 12(4): 323–335.
[27] Gómez AM1, Martínez C, Fiuza-Luces C, Herrero F, Pérez M, Madero L, Ruiz JR, Lucia A, Ramírez M. Exercise training and cytokines in breast cancer survivors. Int J Sports Med. 2011 Jun;32(6):461-7.
[28] Hilberg, T., Gläser, D., Reckhart, C., Prasa, D., Stürzebecher, J., Gabriel, H. H. (2003). Blood coagulation and fibrinolysis after longdurationtreadmill exercise controlled by individual anaerobic threshold. Eur J ApplPhysiol, 90, 639-642.
[29] Kulaputana, O., Richard, F. M., Ioana, G., Dana, A. Ph.,Andrew, P. G., James, M. H. (2005). Human gender differences infibrinolytic responses to exercise training and their determinants, Exp Physio, 90, 881-887.
[30] Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, et al. Role of plasminogen activatorplasmin system in tumor angiogenesis. Cell Mol Life Sci. 2003; 60:463–473.
[31] Beaulieu LM, Whitley BR, Wiesner TF, Rehault SM, Palmieri D, Elkahloun AG, et al. Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays. 2007; 29:1029–1038.
[32] Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, et al. Plasminogen activatorinhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 2001; 61:5587–5594.
[33] McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, et al. Plasminogenactivator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem. 2001; 276:33964–33968.
[34] Steiner E, Pollow K, Hasenclever D, Schormann W, Hermes M, Schmidt M, et al. Role ofurokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1)for prognosis in endometrial cancer. GynecolOncol. 2008; 108:569–576.
[35] DeSouza CA, Jones PP, Seals DR. Physical activity status and adverse age-related differences incoagulation and fibrinolytic factors in women. ArteriosclerThrombVasc Biol. 1998; 18:362–368.
[36] Maleki, Fatemeh, Debiidi Roshan, Wali Allah. (2011). The Effect of Regular Physical Exercises and Exitant Activities Before and After on the Complex of Activating Histogenic and Regulatory Plasminogenins in the Wistar Mice, Sport Sciences, Vol. 5, 109-95.